LOGO
LOGO

Clinical Trial Calendar

Company Name Zenas BioPharma, Inc.
Event Name Safety and efficacy results from Phase 3 trial of obexelimab (INDIGO)
Indication Immunoglobulin G4-Related Disease (IgG4-RD)
Outcome Date
Outcome
Result Date 04-Jun-2026
News